MCID: HYP069
MIFTS: 64

Hyperparathyroidism malady

Genetic diseases, Endocrine diseases, Rare diseases, Cancer diseases categories

Summaries for Hyperparathyroidism

About this section
Sources:
66Wikipedia, 34MalaCards
See all sources

Fully expand this MalaCard

Download this MalaCard
Wikipedia:66 Hyperparathyroidism is overactivity of the parathyroid glands resulting in excess production of... more...

MalaCards: Hyperparathyroidism is related to primary hyperparathyroidism and hyperparathyroidism-jaw tumor syndrome. An important gene associated with Hyperparathyroidism is CDC73 (cell division cycle 73), and among its related pathways are Drug Induction of Bile Acid Pathway and Osteoblast Signaling. The drugs cod liver oil and calcitriol and the compounds calcifediol and pyridinoline have been mentioned in the context of this disorder. Affiliated tissues include bone, kidney and thyroid, and related mouse phenotypes are craniofacial and integument.

Aliases & Classifications for Hyperparathyroidism

About this section
Sources:
9Disease Ontology, 11DISEASES, 46Novoseek, 63UMLS, 59SNOMED-CT, 28ICD9CM, 41NCIt, 36MeSH
See all sources

Classifications:

Malacards categories (disease lists): (See all malacards categories)
Global: Genetic diseases, Rare diseases, Cancer diseases
Anatomical: Endocrine diseases


Aliases & Descriptions:

hyperparathyroidism 9 11 46 63


External Ids:

Disease Ontology9 DOID:13543
ICD9CM28 252.00, 252.0
NCIt41 C48259
MeSH36 D006961

Related Diseases for Hyperparathyroidism

About this section
Sources:
18GeneCards, 19GeneDecks
See all sources

Diseases in the Primary Hyperparathyroidism family:

hyperparathyroidism Hyperparathyroidism 3

Diseases related to Hyperparathyroidism via text searches within MalaCards or GeneCards/GeneDecks gene sharing:

(show top 50)    (show all 302)
idRelated DiseaseScoreTop Affiliating Genes
1primary hyperparathyroidism31.3VDR, CYP27B1, BGLAP, PTH, PTHLH, PRKAR1A
2hyperparathyroidism-jaw tumor syndrome31.2CDC73
3familial isolated hyperparathyroidism31.1MEN1, CDC73
4parathyroid carcinoma31.0PTH, MEN1, CASR, CDC73
5adenoma31.0VDR, PTH, PRKAR1A, RET, MEN1, CASR
6osteitis fibrosa30.9ALPP, CASR, PTH, BGLAP
7multiple endocrine neoplasia30.8PRKAR1A, RET, MEN1, CALCA, CDC73
8parathyroid adenoma30.8VDR, PTH, PTHLH, PRKAR1A, RET, MEN1
9uremia30.7VDR, PTH, MEN1, CASR, NR1I3
10hypercalcemia30.7BGLAP, PTH, PTHLH, PRKAR1A, MEN1, CASR
11nephrocalcinosis30.6CASR, NR1I3
12osteomalacia30.6FGF23, ALPP, CALCA, CASR, VDR, CYP27B1
13osteosclerosis30.6PTH, ALPP
14goiter30.6BGLAP, PTH, RET, CALCA
15renal osteodystrophy30.5VDR, BGLAP, PTH, ACP5, CASR, CALCA
16hyperphosphatemia30.5VDR, PTH, CASR, ALPP, FGF23
17pheochromocytoma30.5RET, MEN1, CALCA
18thyroid cancer30.4RET, CASR, CALCA
19pseudohypoparathyroidism30.4BGLAP, PTH, PTHLH, CALCA
20hyperparathyroidism, neonatal30.4NR1I3, CASR, PRKAR1A
21rickets30.4VDR, CYP27B1, BGLAP, PTH, ACP5, ALPP
22hyperthyroidism30.4BGLAP, PTH, ACP5, ALPP, FGF23
23papillary thyroid carcinoma30.4CALCA, MEN1, RET
24multiple endocrine neoplasia type 2a30.3PTH, RET, MEN1, CALCA, CDC73
25ossifying fibroma30.3CDC73
26giant cell tumor30.2CALCA
27fibrous dysplasia30.2BGLAP, ALPP, FGF23
28nodular goiter30.2RET, CALCA
29calcinosis30.2FGF23, ALPP, CASR, PTH
30paget's disease of bone30.2BGLAP, CALCA
31insulinoma30.2MEN1, CASR, CALCA
32mccune albright syndrome30.1PRKAR1A, FGF23
33nephrolithiasis30.1VDR, PTH, CASR, NR1I3, FGF23
34hypophosphatasia30.1ALPP
35acromegaly30.1BGLAP, PRKAR1A, MEN1
36prolactinoma30.1MEN1, PRKAR1A, PTHLH
37x-linked hypophosphatemia30.1FGF23, CYP27B1, VDR
38hypophosphatemia30.0FGF23, ALPP, CALCA, PTHLH, VDR, CYP27B1
39hypoparathyroidism30.0BGLAP, PTH, PTHLH, PRKAR1A, RET, CASR
40thyroid adenoma30.0PRKAR1A, RET
41myeloma30.0BGLAP, PTHLH, ACP5, ALPP
42osteoporosis30.0CYP27B1, BGLAP, PTH, PTHLH, PRKAR1A, ACP5
43graves' disease30.0VDR, CYP27B1, BGLAP, CASR, FGF23
44secondary hyperparathyroidism of renal origin30.0PTHLH, PRKAR1A, MEN1, ACP5, CASR, CALCA
45hypothyroidism29.9RET, CALCA
46arthritis29.9VDR, BGLAP, ACP5, CALCA, ALPP
47hypervitaminosis d29.9FGF23, CYP27B1
48brachydactyly29.9PTH
49gastrinoma29.8CASR, MEN1
50hyperostosis29.8BGLAP, FGF23

Graphical network of the top 20 diseases related to Hyperparathyroidism:



Diseases related to hyperparathyroidism

Symptoms for Hyperparathyroidism

About this section

Drugs & Therapeutics for Hyperparathyroidism

About this section
Sources:
6CenterWatch, 43NIH Clinical Center, 7ClinicalTrials, 63UMLS, 42NDF-RT
See all sources

Approved drugs:

Search CenterWatch for Hyperparathyroidism

Drug clinical trials:

Search ClinicalTrials for Hyperparathyroidism

Search NIH Clinical Center for Hyperparathyroidism

Search CenterWatch for Hyperparathyroidism

Inferred drug relations via UMLS63/NDF-RT42:

Genetic Tests for Hyperparathyroidism

About this section

Anatomical Context for Hyperparathyroidism

About this section
Sources:
34MalaCards
See all sources

MalaCards organs/tissues related to Hyperparathyroidism:

34
Bone, Kidney, Thyroid, Testes, Endothelial, Liver, Lung, Breast, Pituitary, Pancreatic islet, Bone marrow, Colon, Brain, Skin, Prostate, Thymus, Eye

Animal Models for Hyperparathyroidism or affiliated genes

About this section
Sources:
38MGI
See all sources

MGI Mouse Phenotypes related to Hyperparathyroidism:

38 (show all 18)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053828.9MEN1, PRKAR1A, PTHLH, PTH, VDR
2MP:00107718.6VDR, CYP27B1, PTHLH, CASR, CALCA, CDC73
3MP:00053698.6VDR, PRKAR1A, RET, MEN1, CASR, CDC73
4MP:00053678.4VDR, CYP27B1, PTHLH, RET, CASR, CALCA
5MP:00053888.4PTHLH, PRKAR1A, RET, CALCA, CDC73, FGF23
6MP:00053718.3VDR, CYP27B1, PTH, PTHLH, RET, ACP5
7MP:00053818.2VDR, PTHLH, PRKAR1A, RET, MEN1, CASR
8MP:00053798.1VDR, CYP27B1, PTH, PTHLH, PRKAR1A, RET
9MP:00053808.0PRKAR1A, RET, MEN1, CALCA, ALPP, CDC73
10MP:00053847.9VDR, CYP27B1, PTHLH, PRKAR1A, RET, MEN1
11MP:00053907.8VDR, CYP27B1, PTH, PTHLH, PRKAR1A, ACP5
12MP:00053857.8VDR, PTH, PTHLH, PRKAR1A, RET, MEN1
13MP:00053897.5PRKAR1A, PTHLH, CYP27B1, VDR, RET, MEN1
14MP:00053977.4VDR, CYP27B1, PTH, PTHLH, PRKAR1A, RET
15MP:00053877.3VDR, CYP27B1, PTH, PTHLH, PRKAR1A, RET
16MP:00053767.2PRKAR1A, PTHLH, PTH, CYP27B1, VDR, RET
17MP:00053787.0FGF23, VDR, CYP27B1, PTH, PTHLH, PRKAR1A
18MP:00107686.8RET, PRKAR1A, PTHLH, PTH, VDR, MEN1

Publications for Hyperparathyroidism

About this section
Sources:
53PubMed
See all sources

Articles related to Hyperparathyroidism:

(show top 50)    (show all 1679)
idTitleAuthorsYear
1
Differentiating familial hypocalciuric hypercalcemia from primary hyperparathyroidism. (23425644)
2013
2
Is there a link between Hashimoto's thyroiditis and primary hyperparathyroidism? A study of serum parathormone and anti-TPO antibodies in 2267 patients. (23865082)
2013
3
Intraoperative PTH cutoff definition to predict successful parathyroidectomy in secondary and tertiary hyperparathyroidism. (23929152)
2013
4
Secondary and tertiary hyperparathyroidism. (23267748)
2013
5
The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record. (24383100)
2013
6
The diagnostic value of parathyroid hormone washout after fine-needle aspiration of suspicious cervical lesions in patients with hyperparathyroidism. (23553068)
2013
7
Radiographical appearance of osteitis fibrosa cystica in primary hyperparathyroidism before and after parathyroidectomy. (23365170)
2013
8
Epidemiology of Primary Hyperparathyroidism and its Non-classical Manifestations in the City of Recife, Brazil. (24348080)
2013
9
Progression of aortic valve stenosis is associated with bone remodelling and secondary hyperparathyroidism in elderly patients--the COFRASA study. (23329150)
2013
10
Arterial Hypertension, Metabolic Syndrome and Subclinical Cardiovascular Organ Damage in Patients with Asymptomatic Primary Hyperparathyroidism before and after Parathyroidectomy: Preliminary Results. (22719761)
2012
11
A comparison of outcomes for younger and older adult patients undergoing surgery for primary hyperparathyroidism. (22207049)
2012
12
Accidental discovery of lung metastases from differentiated thyroid cancer by 99mTc sodium pertechnetate scan in a patient with secondary hyperparathyroidism. (22889782)
2012
13
Preoperative a8^a8^mTc-sestamibi scintigraphy in patients with primary hyperparathyroidism and concomitant nodular goiter: comparison of SPECT-CT, SPECT, and planar imaging. (22825041)
2012
14
Primary hyperparathyroidism and familial hypocalciuric hypercalcemia: relationships and clinical implications. (22232026)
2012
15
Transient hyperthyroidism after surgery for secondary hyperparathyroidism: a common problem. (21813380)
2011
16
CDC73-related hereditary hyperparathyroidism: five new mutations and the clinical spectrum. (21652691)
2011
17
Forearm bone mineral density in familial hypocalciuric hypercalcemia and primary hyperparathyroidism: a comparative study. (21785908)
2011
18
Primary hyperparathyroidism patients with positive preoperative sestamibi scan and negative ultrasound are more likely to have posteriorly located upper gland adenomas (PLUGs). (21207169)
2011
19
An association between invasive breast cancer and familial idiopathic hyperparathyroidism: a case series and review of the literature. (18500673)
2009
20
Phosphatemic effect of cinacalcet in kidney transplant recipients with persistent hyperparathyroidism. (18950915)
2008
21
Unusual case of calciphylaxis associated with primary hyperparathyroidism without coexistent renal failure. (18463046)
2008
22
Tc-99m sestamibi uptake mimicking parathyroid adenoma in a patient with primary hyperparathyroidism and occult multiple myeloma. (18287846)
2008
23
Normocalcemic, subclinical, asymptomatic primary hyperparathyroidism in patients with goiter or papillary thyroid cancer--preliminary report. Normocalcemic primary hyperparathyroidism and thyroid pathology. (17966885)
2007
24
Primary hyperparathyroidism due to parathyroid adenoma. (17268723)
2007
25
Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism. (16381997)
2006
26
Prevalence of secondary hyperparathyroidism (SHPT) and causal factors in adult population in ReykjavA-k area]. (16155312)
2005
27
Assessment of therapeutic effect in patients with secondary hyperparathyroidism using bone scintigraphy. (16164192)
2005
28
Inhibition of growth hormone secretion in mild primary hyperparathyroidism. (15249740)
2004
29
The parathyroid hormone-2 receptor is expressed on human leukocytes and down-regulated in hyperparathyroidism. (12834174)
2003
30
The role of hyperparathyroidism, erythropoietin therapy, and CMV infection in the failure of arteriovenous fistula in hemodialysis. (12846770)
2003
31
Regulation of the calcium-sensing receptor. Influence of secondary hyperparathyroidism]. (12778846)
2003
32
Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism. (12699448)
2003
33
Recovery pattern of patients with osteitis fibrosa cystica in primary hyperparathyroidism after successful parathyroidectomy. (12490858)
2002
34
Pathogenesis of refractory secondary hyperparathyroidism. (11982830)
2002
35
Visual vignette. Hyperparathyroidism due to a parathyroid adenoma. (11441818)
2000
36
Vitamin D deficiency and secondary hyperparathyroidism: clinical and biochemical associations in older non-institutionalised Southern Tasmanians. (10833112)
2000
37
Familial isolated hyperparathyroidism: a report of two cases]. (10689881)
2000
38
Molecular mechanisms of primary hyperparathyroidism. (11706744)
2000
39
A randomized trial of sevelamer hydrochloride (RenaGel) with and without supplemental calcium. Strategies for the control of hyperphosphatemia and hyperparathyroidism in hemodialysis patients. (9988142)
1999
40
Lack of relationship between BsmI vitamin D receptor polymorphism and primary hyperparathyroidism in a Spanish female population. (10441653)
1999
41
Novel V184E MEN1 germline mutation in a Japanese kindred with familial hyperparathyroidism. (9843042)
1998
42
Plasma chromogranin A in pheochromocytoma, primary hyperparathyroidism and pituitary adenoma in comparison with catecholamine, parathyroid hormone and pituitary hormones. (9228469)
1997
43
Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen. (8678946)
1996
44
Lack of influence of recombinant human erythropoietin on parathyroid function in hemodialysis patients with secondary hyperparathyroidism. (7566308)
1995
45
Renal function in hyperparathyroidism with complicating nephrocalcinosis. (8453206)
1993
46
Plasma intact parathyroid hormone (PTH) and PTH-related peptide in familial benign hypercalcemia: greater responsiveness to endogenous PTH than in primary hyperparathyroidism. (1997510)
1991
47
Chromogranin A and B in parathyroid tissue of cases of primary hyperparathyroidism: an immunohistochemical study. (2024450)
1991
48
Calciphylaxis in a renal dialysis patient with secondary hyperparathyroidism. (3452312)
1987
49
Nephrocalcinosis, hypercalcemia, sarcoidosis or primary hyperparathyroidism? (3983783)
1985
50
Intracranial calcification in hyperparathyroidism associated with gait apraxia and parkinsonism. (7191528)
1980

Variations for Hyperparathyroidism

About this section

Expression for genes affiliated with Hyperparathyroidism

About this section
Sources:
2BioGPS, 16Gene Expression Omnibus DataSets
See all sources
Expression patterns in normal tissues for genes affiliated with Hyperparathyroidism

Search GEO for disease gene expression data for Hyperparathyroidism.

Pathways for genes affiliated with Hyperparathyroidism

About this section
Sources:
51PathCards, 39NCBI BioSystems Database, 56Reactome, 61Thomson Reuters
See all sources

Compounds for genes affiliated with Hyperparathyroidism

About this section
Sources:
62Tocris Bioscience, 46Novoseek, 12DrugBank, 30IUPHAR, 52PharmGKB, 25HMDB
See all sources

Compounds related to Hyperparathyroidism according to GeneCards/GeneDecks:

(show top 50)    (show all 123)
idCompoundScoreTop Affiliating Genes
1calcifediol6210.0CYP27B1, VDR, NR1I3
2pyridinoline4610.0CALCA, ALPP
3sevelamer469.9FGF23, BGLAP, CASR
4paricalcitol46 1210.8VDR, CYP27B1, PTH
5calcipotriol46 62 30 1212.7NR1I3, BGLAP, VDR, CYP27B1
6thiazide469.7BGLAP, CASR, CALCA, VDR
7etidronic acid46 52 1211.6ALPP, CALCA, VDR
8ipriflavone469.6BGLAP, CALCA, ALPP
9cinacalcet46 30 1211.5CALCA, NR1I3, PRKAR1A, CASR
10gadolinium469.5PRKAR1A, CASR, NR1I3
11alfacalcidol46 62 1211.5CYP27B1, BGLAP, CALCA, VDR, NR1I3
12etidronate469.4CALCA, BGLAP, ALPP
13eb 108946 6210.4VDR, NR1I3, PTHLH, BGLAP, CYP27B1
1424,25-dihydroxyvitamin d3469.2VDR, CYP27B1, BGLAP, ALPP, CALCA
1522-oxacalcitriol469.2ALPP, CASR, VDR, BGLAP, PTHLH
16zoledronic acid469.2BGLAP, PTHLH, CALCA, ALPP
17clodronate46 52 1211.1CALCA, ACP5, VDR, PTHLH, BGLAP
18calcium carbonate469.1BGLAP, PTH, PTHLH, CALCA, ALPP
19neomycin469.0ALPP, NR1I3, PRKAR1A, PTHLH, CASR
20pamidronate46 52 1210.9BGLAP, PTH, PTHLH, CASR, CALCA, ALPP
21procollagen468.8ACP5, PTH, BGLAP, ALPP
22alendronate46 52 1210.8VDR, PTHLH, CALCA, ALPP, BGLAP, PTH
23tartrate468.8BGLAP, PTHLH, CALCA, ACP5, ALPP
24forskolin46 52 1210.8PRKAR1A, PTHLH, CYP27B1, PTH, CALCA, CASR
25thyroxine46 259.8CALCA, PTH, PTHLH, BGLAP, VDR, ALPP
26estradiol46 25 1210.7CYP27B1, BGLAP, PTH, PTHLH, ACP5, NR1I3
27deoxypyridinoline468.7ALPP, CALCA, ACP5, PTH, BGLAP, VDR
28hydroxyapatite468.6ALPP, BGLAP, ACP5, CASR, FGF23, PTHLH
29hydroxyproline46 25 1210.5CALCA, ALPP, ACP5, PTHLH, PTH, BGLAP
30cyclosporin a46 30 6210.4CALCA, CASR, BGLAP, ALPP, NR1I3, ACP5
31paraffin468.3ACP5, RET, PTHLH, ALPP, BGLAP, CYP27B1
32cyclic amp46 259.3NR1I3, CALCA, CASR, RET, PRKAR1A, CYP27B1
33thymidine46 259.2ALPP, NR1I3, MEN1, VDR, PTHLH, PTH
34vegf468.0CALCA, MEN1, BGLAP, PTHLH, PTH, ALPP
35alanine468.0ALPP, NR1I3, CASR, PTHLH, RET, BGLAP
36testosterone46 62 25 1210.9NR1I3, ALPP, CALCA, RET, PTHLH, VDR
37pge2467.8VDR, PTHLH, ACP5, CASR, CALCA, PTH
38dexamethasone46 52 30 1210.8PTH, BGLAP, VDR, ALPP, ACP5, PTHLH
39cysteine467.8VDR, ACP5, CASR, ALPP, PRKAR1A, BGLAP
40serine467.8PTHLH, BGLAP, VDR, RET, MEN1, CASR
41tyrosine467.8ACP5, MEN1, CYP27B1, RET, PTH, CASR
42creatinine467.8VDR, BGLAP, FGF23, PTH, PTHLH, CASR
4325-hydroxyvitamin d467.6BGLAP, PTH, PTHLH, ACP5, CASR, CALCA
44arginine467.5FGF23, NR1I3, BGLAP, PTH, PTHLH, CASR
45estrogen467.3ALPP, CYP27B1, PTH, NR1I3, CALCA, CASR
461,25 dihydroxy vitamin d3467.3PTHLH, ACP5, CASR, CALCA, ALPP, NR1I3
47calcitriol46 62 25 1210.3ALPP, CALCA, CASR, ACP5, PTHLH, PTH
48phosphorus467.3VDR, CYP27B1, BGLAP, PTH, PTHLH, ACP5
49vitamin d466.6VDR, CYP27B1, BGLAP, PTH, FGF23, PTHLH
50calcium46 52 25 129.2ACP5, CASR, MEN1, RET, PRKAR1A, PTHLH

GO Terms for genes affiliated with Hyperparathyroidism

About this section
Sources:
17Gene Ontology
See all sources

Cellular components related to Hyperparathyroidism according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1extracellular spaceGO:0056158.9FGF23, CALCA, PTHLH, PTH, BGLAP

Biological processes related to Hyperparathyroidism according to GeneCards/GeneDecks:

(show all 19)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of keratinocyte differentiationGO:04561810.2CYP27B1, VDR
2vitamin D catabolic processGO:04236910.2CYP27B1, FGF23
3decidualizationGO:04669710.1CYP27B1, VDR
4cAMP metabolic processGO:04605810.1PTH, PTHLH
5regulation of bone mineralizationGO:03050010.1CYP27B1, BGLAP
6positive regulation of vitamin D 24-hydroxylase activityGO:01098010.0FGF23, CYP27B1, VDR
7response to vitamin DGO:03328010.0PTH, BGLAP, CYP27B1
8cellular calcium ion homeostasisGO:00687410.0CASR, PTH, VDR
9bone mineralizationGO:0302829.9BGLAP, CYP27B1
10response to painGO:0482659.9RET, CALCA
11osteoblast developmentGO:0020769.8BGLAP, PTHLH, MEN1
12positive regulation of cAMP biosynthetic processGO:0308199.8CALCA, PTHLH, PTH
13adenylate cyclase-activating G-protein coupled receptor signaling pathwayGO:0071899.8PTH, PTHLH, CALCA
14bone resorptionGO:0454539.7ACP5, PTH
15transcription initiation from RNA polymerase II promoterGO:0063679.6VDR, MEN1, NR1I3
16skeletal system developmentGO:0015019.6PTHLH, PTH, BGLAP, VDR
17negative regulation of cell proliferationGO:0082859.5VDR, CYP27B1, PTHLH, MEN1, CDC73
18negative regulation of transcription, DNA-templatedGO:0458929.4VDR, MEN1, CALCA, NR1I3
19negative regulation of transcription from RNA polymerase II promoterGO:0001229.2CDC73, MEN1, PTH, VDR

Molecular functions related to Hyperparathyroidism according to GeneCards/GeneDecks:

idNameGO IDScoreTop Affiliating Genes
1peptide hormone receptor bindingGO:0514289.8PTHLH, PTH
2hormone activityGO:0051799.2CALCA, PTHLH, PTH

Products for genes affiliated with Hyperparathyroidism

About this section
  • Antibodies
  • Proteins
  • Lysates
  • Antibodies

Sources for Hyperparathyroidism

About this section
4CDC
14ExPASy
15FMA
23GTR
24HGMD
25HMDB
26ICD10
27ICD10 via Orphanet
28ICD9CM
30IUPHAR
31KEGG
36MeSH
37MESH via Orphanet
38MGI
41NCIt
42NDF-RT
45NINDS
46Novoseek
48OMIM
49OMIM via Orphanet
53PubMed
54QIAGEN
60SNOMED-CT via Orphanet
63UMLS
64UMLS via Orphanet